Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2027?

Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2027? It is currently trading at a 12% probability on Kalshi. Scheduled resolution: January 1, 2032.

Last updated September 1, 2026 at 1:40 AM ET

Current Market Probability

Probability Price Platform Status Resolution date Chart
12% 0.12 Kalshi Open January 01, 2032 View chart

Market Information

Historical Market Probability

7 days ago 30 days ago Current
10% 9% 12%

Related Prediction Markets

Popular Prediction Markets